Эндометриоз: поиск фарматерапевтического компромисса

Authors

  • Н. Ф. Захаренко Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine
  • Н. В. Косей Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine
  • Л. М. Коломиец PH "Trilist", Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2012.4.52-57

Abstract

Уже много лет эндометриоз, без преувеличения, представляет собой предмет пристального внимания клиницистов. Это обусловлено тем, что данное заболевание входит в тройку лидеров патологий женской половой системы, уступая лишь воспалительным заболеваниям придатков и миоме матки. По оценкам различных авторов, частота эндометриоза у женщин репродуктивного возраста составляет от 5 до 10% и достигает 15-30% среди пациенток с первичным или вторичным бесплодием [1, 2]. Усугубляет положение тот факт, что эндометриоз не имеет «популяционной тропности» и поражает наиболее активную часть женской популяции, т.е. встречается преимущественно у женщин репродуктивного возраста вне зависимости от этнической и социальной принадлежности.

Author Biographies

Н. Ф. Захаренко, Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine

MD, chief researcher at the Endocrine Gynecology Department

Н. В. Косей, Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine

MD, Chief Scientist at the Department of Endocrine Gynecology

Л. М. Коломиец, PH "Trilist"

Research Medical Editor

References

  1. ESHRE guideline for the diagnosis and treatment of endometriosis. June 2007.
  2. RCOG Standart: Investigation аnd Management оf Endometriosis. October 2006.
  3. SOGC Clinical Practice Guideline: Endometriosis: Diagnosis and Management. July 2010.
  4. Joseph C. Gambone et al. Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process. Chronic Pelvic Pain/Endometriosis Working Group, UCLA Medical School, Los Angeles, California Fertility аnd Sterility. 2002. Vol. 78, Nо. 5.
  5. Cosson M., Querleu D., Donnez J., Madelenat P., Koninckx P., Audebert A., Manhes H. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertility and Sterility. April 2002, Vol. 77, No. 4.
  6. Filicori M., Flamigni C., Cognigni G., Dellai P. Rossella arnone, angela falbo, and maurizio capelli. Comparison of the Suppressive Capacity of Different Depot Gonadotropin-Releasing Hormone Analogs in Women. Journal of Clinicei Endocrinology and Metabolism. 1993. Vol. 17, No. 1.
  7. Strowitzki1 T., Marr J., Gerlinger C., Faustmann T., Seitz C. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Human Reproduction, 2010. Vol. 00, No. 0, 1-9 pp.
  8. Tasuku Harada, Mikio Momoeda, Yuji Taketani, Takeshi Aso, Masao Fukunaga, Hiroshi Hagino, Naoki Terakawa. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial. Fertility and Sterility. 2008.
  9. Леваков С.А., Хамошина М.Б. Эндометриоз: мировой прорыв в медикаментозном лечении. – М.: Редакция журнала Status Praesens, 2012. – 16 с.

Downloads

Published

2012-04-13

How to Cite

Захаренко, Н. Ф., Косей, Н. В., & Коломиец, Л. М. (2012). Эндометриоз: поиск фарматерапевтического компромисса. REPRODUCTIVE ENDOCRINOLOGY, (4), 52–57. https://doi.org/10.18370/2309-4117.2012.4.52-57

Issue

No. 4 (2012)

Section

Gynecology

License

Copyright (c) 2014 Н. Ф. Захаренко, Н. В. Косей, Л. М. Коломиец

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.